Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-205

You took a low blow mate. Say what you want about Mason, if we all listened to him regarding Hervax we'd be much more wealthy, probably selling near ATHs. None of us expect 2years after 60c we wouldn't have a deal. Now the multi billion dollar sale figures the pumpers throw out have turned to a few hundred million, to 'I hope they can sell the Bcell format bundles with something else'.

Forget RAC and any ulterior motives, he said Hervax was a dud and it turns out he was right. 1/1. Now he's after CF33 but did say we need to see the next data cut and hopes he is wrong.

I say bring on the next VAXINIA results and have Mason do a breakdown again. Here's hoping the next results are so amazing he joins the IMU camp as an investor. You are more than welcome to jump ship @Mason14